Abstract

The subchondral bone and its associated vasculature play an important role in the onset of osteoarthritis (OA). Integration of different aspects of the OA environment into multi-cellular and complex human, in vitro models is therefore needed to properly represent the pathology. In this study, we exploited a mesenchymal stromal cell line/endothelial cell co-culture to produce an in vitro human model of vascularized osteogenic tissue. A cocktail of inflammatory cytokines, or conditioned medium from mechanically-induced OA engineered microcartilage, was administered to this vascularized bone model to mimic the inflamed OA environment, hypothesizing that these treatments could induce the onset of specific pathological traits. Exposure to the inflammatory factors led to increased network formation by endothelial cells, reminiscent of the abnormal angiogenesis found in OA subchondral bone, demineralization of the constructs, and increased collagen production, signs of OA related bone sclerosis. Furthermore, inflammation led to augmented expression of osteogenic (alkaline phosphatase (ALP) and osteocalcin (OCN)) and angiogenic (vascular endothelial growth factor (VEGF)) genes. The treatment, with a conditioned medium from the mechanically-induced OA engineered microcartilage, also caused increased demineralization and expression of ALP, OCN, ADAMTS5, and VEGF; however, changes in network formation by endothelial cells were not observed in this second case, suggesting a possible different mechanism of action in inducing OA-like phenotypes. We propose that this vascularized bone model could represent a first step for the in vitro study of bone changes under OA mimicking conditions and possibly serve as a tool in testing anti-OA drugs.

Highlights

  • Generation of 3D Constructs Made of Mesenchymal cells Sword of Damocles (MSODs) and HUVECs Co-Cultured in gelatin methacrylate (gelMA)

  • MSODs and HUVECs embedded in photocrosslinked gelatin methacrylate

  • A decrease of glucose concentration in the medium was registered from day 7 to day 14 for MSODs and MSOD-HUVECs, while the concentration of the metabolite remained unchanged in HUVECs alone

Read more

Summary

Introduction

The aging population has led osteoarthritis (OA) to become the most prevalent degenerative and disability-causing joint disease worldwide, with a huge burden on economics and social welfare [1]. Despite OA prevalence, research has made insufficient progress on the development of disease modifying therapies. Blood vessels invade the otherwise avascular cartilage and the whole OA joint is characterized by a state of low-grade inflammation with the production of IL-1β, TNFα, and IL-6 by cartilage, and by the thickened and inflamed synovium [5]. The tight interaction between bone and cartilage, coupled with the chronic inflamed environment, renders it extremely complex to identify the molecular triggers of early stages of OA [6], and there is still no consensus in the scientific community concerning OA origin [7]

Methods
Results
Discussion
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.